Menton, France

Gilles Pellegrino



 

Average Co-Inventor Count = 4.4

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2015-2016

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Gilles Pellegrino

Introduction

Gilles Pellegrino is a notable inventor based in Menton, France. He has made significant contributions to the field of chemistry, particularly in the development of processes related to bicyclic structures and steroid compounds. With a total of two patents to his name, Pellegrino's work showcases his expertise and innovative spirit.

Latest Patents

Pellegrino's latest patents include a process for isomerizing fused bicyclic structures and the preparation of vitamin D analogs. This invention focuses on isomerizing trans fused bicyclic derivatives into cis fused bicyclic derivatives, which is crucial for the synthesis of vitamin D and its analogs. Another significant patent involves a process for introducing a double bond into position 15, 16 of a steroid. This invention details the preparation of a compound that serves as an intermediate in the production of gestodene, a synthetic progestin.

Career Highlights

Throughout his career, Gilles Pellegrino has worked with various companies, including Hybrigenics S.A. and Laboratoire Theramex. His experience in these organizations has allowed him to refine his skills and contribute to important advancements in pharmaceutical chemistry.

Collaborations

Pellegrino has collaborated with notable colleagues such as Jean-Luc Moutou and Florent Mouton. These partnerships have likely enriched his research and development efforts, leading to innovative solutions in his field.

Conclusion

Gilles Pellegrino's contributions to the field of chemistry through his patents and collaborations highlight his role as an influential inventor. His work continues to impact the development of important compounds and processes in the pharmaceutical industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…